One of the more aggressive PhRMA submissions to the USTR Special 301 list is the section on the Philippines. Excerpts, which are given below, illustrate the breath of PhRMA’s demands on the USTR. Continue Reading →
There are plans for the next ACTA negotiation to take place in Rabat, Morocco. However, since none of the Obama trade people have been placed at USTR, this might be delayed.
The USTR is still maintaining secrecy over details of the negotiation, including the names of participants and all of the proposed texts for negotiations. Despite this, KEI has obtained some documents related to the negotiations. We can report the following:
Continue Reading →
On November 25, 2008, I was invited to give a talk in Vienna, at the meeting of the Chamber of Commerce (the WKO). The event was organized by Eva Lichtenberger, a Green Party MEP. Eva also spoke, and gave a great talk, in German. Her slides were in English, and I’ll add them when I can. The outline of my talk is given below.
Continue Reading →
On November 25, 2008, I was invited to give a talk in Vienna, at the meeting of the Chamber of Commerce (the WKO). The event was organized by Eva Lichtenberger, a Green Party MEP. Eva also spoke, and gave a great talk, in German. Her slides were in English, and I’ll add them when I can. The outline of my talk is given below.
Continue Reading →
KEI has filed comments on the EC’s Green Paper on Copyright in the Knowledge Economy. Here are pdf and odt copies. The html version follows below. Comments of Knowledge Ecology International (KEI) on the GREEN PAPER: Copyright in the Knowledge… Continue Reading →
I have been asked to elaborate on the relationship between the Medical Innovation Prize Fund (S.2210, 110th Congress) and the WTO TRIPS Agreement.
For centuries, innovation inducement prizes have been suggested as a mechanism to stimulate investments in a wide range of topics. (See, for example, Selected Innovation Prizes and Reward Programs, KEI Research Note 2008:1). During most of this period, the patent system has also existed.
Continue Reading →
I arrived at WIPO yesterday for Day 1 which started at 12pm. The delegates and NGOs went for lunch at 1pm and the meeting started again in the afternoon. I’m not sure it was because of jetlag but the meeting did not make much sense. The Chair was re-elected (of course) and he just talked, talked and talked.
Day 2
Continue Reading →
KEI statement on bipartisan trade agreement
14 May 2007
FMI: James Love james.love@keionline.org, +1.202.361.3040
On May 10, 2007, Speaker Nancy Pelosi and Ways and Means Chair Charles Rangel announced a “new bipartisan ” trade package. KEI has reviewed the details of the elements of section III of the agreement, concerning “patents, IPR and access to medicine.”
Continue Reading →
(When the shoe was on the other foot, Abbott asked for a compulsory license, while criticizing Thailand for issuing compulsory licenses) On the 12th of January 2007, Abbott Laboratories lost a bid in a U.S. District Court (the Western District… Continue Reading →
Schumer’s October 16, 2005 press release As Avian Flu Closes In On U.S., Schumer Calls For Immediate Action: Demands Suspension Of Tamiflu Patent So Vaccine Can Be Mass-Produced, Dramatically Increasing Supply Tamiflu, the Only Effective Treatment of Bird Flu in… Continue Reading →